KCNJ11 rs5215: Understanding This Pharmacogenomic Variant
The rs5215 variant is a genetic polymorphism located within the KCNJ11 gene, which is involved in regulating insulin secretion. It is categorized as a pharmacogenomic variant with documented low-level evidence regarding its potential influence on metabolic drug responses.
What each genotype means
Typical KCNJ11 variant profile
This genotype represents the common form of the rs5215 variant in many populations. Research into this variant's role in type 2 diabetes susceptibility has yielded mixed results across different ethnic groups, and it is considered to have low-level clinical evidence. Please discuss any concerns regarding metabolic health or medication response with your clinician or pharmacist.
The C allele is common globally, though frequencies vary significantly by ancestry, with higher representation observed in some European and Italian populations.
Heterozygous variant profile
Carrying one copy of the T allele has been investigated for potential associations with type 2 diabetes risk, though findings are inconsistent across different studies and populations. Because the evidence for this variant is limited and mixed, it should not be used to predict individual health outcomes. Please consult your healthcare provider to discuss your specific health profile and any relevant clinical testing.
This heterozygous genotype is found at varying frequencies worldwide, reflecting the common distribution of both C and T alleles in human populations.
Increased variant frequency profile
Some research has suggested that the TT genotype may be associated with an increased risk of type 2 diabetes in certain populations, though these findings have not been consistently replicated across all ethnic groups. This variant is categorized as having low-level clinical evidence, meaning its impact on individual health is not well-established. You should discuss your metabolic health and any relevant family history with your doctor.
The T allele is the major allele in many global populations, making the TT genotype relatively common in various ancestral groups.
What is rs5215?
The rs5215 variant is a single nucleotide polymorphism (SNP) located within the KCNJ11 gene. In genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. The KCNJ11 gene provides instructions for making a protein that forms part of an inward-rectifier potassium channel. These channels are critical for the function of pancreatic beta cells, which are responsible for producing and releasing insulin in response to blood sugar levels. Because of its location and function, researchers have long investigated whether variations in this gene might influence how the body manages glucose or responds to certain medications used to treat metabolic conditions.
Research and Evidence Strength
Research into rs5215 has primarily focused on its potential association with Type 2 diabetes susceptibility and metabolic traits. While some studies have observed statistical associations between this variant and diabetes risk, the evidence is considered to be at a low or moderate level. For instance, some case-control studies have reported differences in genotype distribution between individuals with diabetes and healthy controls, suggesting a potential link. However, other studies have found inconsistent results, highlighting the complexity of genetic influences on metabolic health. Because the evidence is limited and often varies by population, it is not currently used as a definitive diagnostic tool. It remains a subject of ongoing scientific inquiry rather than a standard clinical marker.
Population Frequency
The frequency of the rs5215 variant is known to be variable across different global populations. Genetic studies, including those comparing Tunisian and Italian cohorts, have highlighted significant differences in the distribution of this variant between various ethnic and regional groups. Because allele frequencies can differ substantially based on ancestry, it is difficult to assign a single 'normal' frequency to the global population. Researchers use large-scale databases to track these differences, which helps in understanding how genetic diversity impacts the prevalence of specific traits or drug responses in different parts of the world.
What You Can Do With This Information
Understanding your genetic variants can be an educational experience, but it is important to maintain realistic expectations regarding their clinical utility. Because the evidence for rs5215 is currently limited and not considered actionable for routine medical decision-making, it should not be used to guide personal health choices or medication adjustments. Genetic associations are often complex and influenced by many other genes, as well as environmental and lifestyle factors. If you have questions about your metabolic health, blood sugar management, or the medications you are taking, the most appropriate step is to consult with your physician or a qualified pharmacist. They can provide personalized guidance based on your complete medical history and current clinical guidelines.
How common is this variant?
The frequency of the rs5215 variant is highly variable across different ancestral groups, with significant differences observed between populations such as those in North Africa and Europe.
Frequently asked questions
Is rs5215 a diagnostic test for diabetes?
No, rs5215 is not a diagnostic test for diabetes. While it has been studied for its potential association with metabolic traits, the evidence is not strong enough to use it for clinical diagnosis.
Should I change my medication based on my rs5215 genotype?
You should never change your medication based on genetic information without consulting your doctor. Always speak with your healthcare provider or pharmacist before making any changes to your prescribed treatment.
Where can I find more information about KCNJ11?
You can find reliable information about the KCNJ11 gene and its functions through resources like MedlinePlus Genetics or the NCBI Gene database.
Why do different studies report different results for rs5215?
Genetic associations can be influenced by population-specific factors, sample sizes, and environmental variables. These differences often lead to varying results across different research studies.
Sources & further reading
Educational information only, last refreshed 11/3/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs5215?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants
A variant characterized as a clinically relevant pharmacogenomic marker studied for its role in drug response variability.
This variant (Ile105Val) in the GSTP1 gene is a well-characterized polymorphism associated with altered enzymatic activity and differential detoxification of xenobiotics and environmental pollutants.
Carriers of the T or C alleles at this locus require adjusted warfarin dosing due to its role in vitamin K metabolism.
This SNP is part of the CYP2C cluster and shows significant frequency variation in Native American populations, impacting metabolic profiles.
Carriers of the A allele show a more pronounced reduction in body weight when treated with the SGLT2 inhibitor dapagliflozin.
This variant in the kappa-opioid receptor gene is linked to behavioral variations in heroin quit attempts and alcohol-related adverse consequences.